Marinomed Biotech AG | WebDisclosure

Basculer en Français

10108	Companies
207161	Keywords
137291	Articles
109798	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 09/16/2025 at 15:22, 6 months 12 days ago

EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share
Marinomed Biotech AG resolves capital increase by issuing 61.607 bearer shares at EUR 17,50 per share, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 17,50
BRIEF

published on 09/01/2025 at 12:01, 6 months 27 days ago

Marinomed Biotech AG obtient un accord d'émission d'obligations convertibles de 2,5 millions d'euros

Financement Stratégie D'investissement Droits Des Actionnaires Marinomed Biotech Obligation Convertible
BRIEF

published on 09/01/2025 at 12:01, 6 months 27 days ago

Marinomed Biotech AG Secures EUR 2.5 Million Convertible Bond Agreement

Financing Investment Strategy Shareholder Rights Convertible Bond Marinomed Biotech
PRESS RELEASE

published on 09/01/2025 at 11:56, 6 months 27 days ago

EQS-Adhoc: Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
Marinomed Biotech AG announces agreement on key terms for a secured EUR 2.5mn convertible bond issue, including interest rate and conversion price

Marinomed Biotech AG Convertible Bond Secured EUR 2.5mn Key Terms
BRIEF

published on 06/30/2025 at 12:56, 8 months 28 days ago

Marinomed Biotech AG : Perspectives positives dans un contexte de redressement stratégique

Restructuration Financière Marinomed Biotech AG Innovation Biotechnologique Plateforme Marinosolv® Développement Budesolv
BRIEF

published on 06/30/2025 at 12:56, 8 months 28 days ago

Marinomed Biotech AG: Positive Outlook Amidst Strategic Turnaround

Marinomed Biotech AG Financial Restructuring Biotech Innovation Marinosolv® Platform Budesolv Development
PRESS RELEASE

published on 06/30/2025 at 12:51, 8 months 28 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Marinomed Biotech AG with a Buy rating and EUR 50.00 price target. Details of the company's dual business model and lead candidate, Budesolv, are highlighted

First Berlin Equity Research BUY Rating Marinomed Biotech AG Biotech Company Dual Business Model
BRIEF

published on 06/06/2025 at 15:25, 9 months 22 days ago

Marinomed Biotech AG Partners to Launch Budesolv in Switzerland

International Expansion Marinomed Biotech AG Milestone Payments Pharma Partnership Budesolv Switzerland
BRIEF

published on 06/06/2025 at 15:25, 9 months 22 days ago

Marinomed Biotech AG s'associe pour lancer Budesolv en Suisse

Expansion Internationale Marinomed Biotech AG Paiements D'étape Partenariat Pharmaceutique Budesolv Suisse
PRESS RELEASE

published on 06/06/2025 at 15:20, 9 months 22 days ago

Marinomed Biotech AG announces partnership for Budesolv in Switzerland
Marinomed Biotech AG announces partnership with Swiss pharmaceutical company for the development and marketing of Budesolv in Switzerland, enabling milestone payments and royalties

Pharmaceutical Company Partnership Switzerland Marinomed Biotech AG Budesolv

Accesswire

Published on 03/28/2026 at 01:00, 1 day 4 hours ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 4 hours ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 1 day 4 hours ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 1 day 6 hours ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 1 day 7 hours ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 10:05, 19 hours 25 minutes ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 20 hours 33 minutes ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 3 hours ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 7 hours ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 1 day 7 hours ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025

Les Echos

Published on 03/28/2026 at 07:00, 22 hours 30 minutes ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 1 day 10 hours ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 1 day 10 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 1 day 10 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 1 day 10 hours ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE